Xttrium Laboratories Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CHLORHEXIDINE GLUCONATE 20% SOLUTION USP, with a corresponding US DMF Number 5782.
Remarkably, this DMF maintains an Active status since its submission on April 08, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2012, and payment made on November 27, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II